Ensemble of hybrid neural network learning approaches for designing pharmaceutical drugs

Designing drugs is a current problem in the pharmaceutical research. By designing a drug we mean to choose some variables of drug formulation (inputs), for obtaining optimal characteristics of drug (outputs). To solve such a problem we propose an ensemble of three learning algorithms namely an evolutionary artificial neural network, Takagi-Sugeno neuro-fuzzy system and an artificial neural network. The ensemble combination is optimized by a particle swarm optimization algorithm. The experimental data were obtained from the Laboratory of Pharmaceutical Techniques of the Faculty of Pharmacy in Cluj-Napoca, Romania. Bootstrap techniques were used to generate more samples of data since the number of experimental data was low due to the costs and time durations of experimentations. Experiment results indicate that the proposed methods are efficient.

[1]  Ajith Abraham,et al.  Neuro Fuzzy Systems: Sate-of-the-Art Modeling Techniques , 2001, IWANN.

[2]  John Hallam,et al.  Artificial intelligence and robotics in high throughput post-genomics. , 2005, Drug discovery today.

[3]  Frank R. Burden,et al.  Bayesian neural nets for modeling in drug discovery , 2004 .

[4]  Heather J. Ruskin,et al.  Probabilistic models for drug dissolution. Part 1. Review of Monte Carlo and stochastic cellular automata approaches , 2006, Simul. Model. Pract. Theory.

[5]  Ajith Abraham,et al.  Engineering Drug Design Using a Multi-Input Multi-Output Neuro-Fuzzy System , 2006, 2006 Eighth International Symposium on Symbolic and Numeric Algorithms for Scientific Computing.

[6]  Tim Hesterberg,et al.  Bootstrap Methods and Permutation Tests* 14.1 the Bootstrap Idea 14.2 First Steps in Using the Bootstrap 14.3 How Accurate Is a Bootstrap Distribution? 14.4 Bootstrap Confidence Intervals 14.5 Significance Testing Using Permutation Tests Introduction , 2004 .

[7]  Tamás Kiss,et al.  From electric patterns to drugs: perspectives of computational neuroscience in drug design. , 2006, Bio Systems.

[8]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[9]  Weiliang Zhu,et al.  New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery , 2006, Drug Discovery Today: Technologies.

[10]  Robert Fullér,et al.  Multiobjective optimization with linguistic variables , 1998 .

[11]  S. Agatonovic-Kustrin,et al.  Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.

[12]  GuanHua Chen,et al.  A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. , 2006, Journal of molecular graphics & modelling.

[13]  P. Érdi,et al.  Computational neuropharmacology: dynamical approaches in drug discovery. , 2006, Trends in pharmacological sciences.

[14]  M. Møller A Scaled Conjugate Gradient Algorithm for Fast Supervised Learning , 1990 .

[15]  Bernard F. Buxton,et al.  Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..

[16]  Tae Gyu Chang,et al.  Evolving Neural Networks for Pharmaceutical Research , 2006, 2006 International Conference on Hybrid Information Technology.

[17]  Abby L. Parrill,et al.  Evolutionary and genetic methods in drug design , 1996 .

[18]  Martin Fodslette Meiller A Scaled Conjugate Gradient Algorithm for Fast Supervised Learning , 1993 .

[19]  Jure Zupan,et al.  Optimization algorithms and natural computing in drug discovery. , 2004, Drug discovery today. Technologies.

[20]  Philip Doble,et al.  Chemical profiling and classification of illicit heroin by principal component analysis, calculation of inter sample correlation and artificial neural networks. , 2005, Talanta.

[21]  William J Welsh,et al.  Shape Signatures: speeding up computer aided drug discovery. , 2006, Drug discovery today.

[22]  Harvey Goldstein,et al.  A nonparametric bootstrap for multilevel models , 2002 .

[23]  Abdelhak M. Zoubir,et al.  Bootstrap Techniques for Signal Processing: Bootstrap M atlab Toolbox , 2004 .

[24]  Yixin Chen,et al.  Application of artificial neural networks in the design of controlled release drug delivery systems. , 2003, Advanced drug delivery reviews.

[25]  K. Stewart,et al.  Drug Guru: a computer software program for drug design using medicinal chemistry rules. , 2006, Bioorganic & medicinal chemistry.

[26]  Christer Carlsson,et al.  Multiobjective optimization with linguistic variables , 1998 .

[27]  James Kennedy,et al.  Particle swarm optimization , 1995, Proceedings of ICNN'95 - International Conference on Neural Networks.

[28]  E. Mizutani,et al.  Neuro-Fuzzy and Soft Computing-A Computational Approach to Learning and Machine Intelligence [Book Review] , 1997, IEEE Transactions on Automatic Control.

[29]  Kozo Takayama,et al.  Neural network based optimization of drug formulations. , 2003, Advanced drug delivery reviews.

[30]  Ana Barat,et al.  Probabilistic models for drug dissolution , 2006 .

[31]  Johann Gasteiger,et al.  Neural networks and genetic algorithms in drug design , 2001 .